Janzen, Mark L <br/><br/>
Clopidogrel and 1-year freedom from amputation after endovascular lower extremity revascularization in the Medicare population.  [electronic resource] 

 -  Vascular and endovascular surgery   
 - 509-15 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1938-9116 
<br/><br/><label>Standard No.: </label>10.1177/1538574414561233  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Amputation, Surgical--adverse effects<br/>Clopidogrel<br/>Disease-Free Survival<br/>Endovascular Procedures--adverse effects<br/>Female<br/>Humans<br/>Kaplan-Meier Estimate<br/>Limb Salvage<br/>Lower Extremity--blood supply<br/>Male<br/>Medicare<br/>Peripheral Arterial Disease--diagnosis<br/>Platelet Aggregation Inhibitors--therapeutic use<br/>Proportional Hazards Models<br/>Retrospective Studies<br/>Risk Factors<br/>Ticlopidine--analogs & derivatives<br/>Time Factors<br/>Treatment Outcome<br/>United States